Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 343

1.

Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.

Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM.

Nature. 2002 Mar 21;416(6878):337-9.

PMID:
11907582
2.

Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases.

Khan SA, Skaf MW, Harrison RW, Lee K, Minhas KM, Kumar A, Fradley M, Shoukas AA, Berkowitz DE, Hare JM.

Circ Res. 2003 Jun 27;92(12):1322-9. Epub 2003 May 22.

3.

Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes.

Ashley EA, Sears CE, Bryant SM, Watkins HC, Casadei B.

Circulation. 2002 Jun 25;105(25):3011-6.

4.

Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.

Bendall JK, Damy T, Ratajczak P, Loyer X, Monceau V, Marty I, Milliez P, Robidel E, Marotte F, Samuel JL, Heymes C.

Circulation. 2004 Oct 19;110(16):2368-75. Epub 2004 Oct 4.

5.

Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.

Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL.

Circulation. 2004 Oct 26;110(17):2666-72. Epub 2004 Oct 18.

6.

Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts.

Gödecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J.

J Physiol. 2001 Apr 1;532(Pt 1):195-204.

7.

Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase.

Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R.

Nat Med. 1999 Mar;5(3):331-4.

PMID:
10086391
8.

Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3.

Champion HC, Georgakopoulos D, Takimoto E, Isoda T, Wang Y, Kass DA.

Circ Res. 2004 Mar 19;94(5):657-63. Epub 2004 Jan 29.

9.

Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice.

Barouch LA, Cappola TP, Harrison RW, Crone JK, Rodriguez ER, Burnett AL, Hare JM.

J Mol Cell Cardiol. 2003 Jun;35(6):637-44.

PMID:
12788381
10.

Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy.

Funakoshi H, Kubota T, Kawamura N, Machida Y, Feldman AM, Tsutsui H, Shimokawa H, Takeshita A.

Circ Res. 2002 May 17;90(9):959-65.

11.

Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.

Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Kitamura S, Tomoike H, Hori M, Kitakaze M.

Circulation. 2004 Aug 10;110(6):692-9. Epub 2004 Jul 19.

12.

Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.

Ohsawa Y, Toko H, Katsura M, Morimoto K, Yamada H, Ichikawa Y, Murakami T, Ohkuma S, Komuro I, Sunada Y.

Hum Mol Genet. 2004 Jan 15;13(2):151-7. Epub 2003 Nov 25.

PMID:
14645200
13.

Modulation of mouse cardiac function in vivo by eNOS and ANP.

Gyurko R, Kuhlencordt P, Fishman MC, Huang PL.

Am J Physiol Heart Circ Physiol. 2000 Mar;278(3):H971-81.

14.

Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy.

Cappola TP, Cope L, Cernetich A, Barouch LA, Minhas K, Irizarry RA, Parmigiani G, Durrani S, Lavoie T, Hoffman EP, Ye SQ, Garcia JG, Hare JM.

Physiol Genomics. 2003 Jun 24;14(1):25-34.

PMID:
12709511
15.

Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.

Amour J, Loyer X, Le Guen M, Mabrouk N, David JS, Camors E, Carusio N, Vivien B, Andriantsitohaina R, Heymes C, Riou B.

Anesthesiology. 2007 Sep;107(3):452-60.

PMID:
17721248
16.

Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.

Brunner F, Andrew P, Wölkart G, Zechner R, Mayer B.

Circulation. 2001 Dec 18;104(25):3097-102.

17.

Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha.

Funakoshi H, Kubota T, Machida Y, Kawamura N, Feldman AM, Tsutsui H, Shimokawa H, Takeshita A.

Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2159-66.

18.

Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.

Drexler H, Kästner S, Strobel A, Studer R, Brodde OE, Hasenfuss G.

J Am Coll Cardiol. 1998 Oct;32(4):955-63.

19.

[Significance of neuronal, endothelial and inducible NO-synthase isoforms in the cardiac muscle histophysiology].

Okhotin VE, Shuklin AV.

Morfologiia. 2006;129(1):7-17. Review. Russian.

PMID:
17201313
20.

Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes.

Ostrom RS, Bundey RA, Insel PA.

J Biol Chem. 2004 May 7;279(19):19846-53. Epub 2004 Mar 8.

Supplemental Content

Support Center